Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

NCT04445987 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
408
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Arcutis Biotherapeutics, Inc.